Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of olaparib combined with dabrafenib and trametinib for a patient with BRAF mutated and ATM deleted metastatic melanoma.
Marguet T, Mouret S, Belbézier A, Castillo-Ferrer C, Sancey L, Porret P, Templier I, Hurbin A, Frachet V, Amini-Adle M, Malissen N, Charles J. Marguet T, et al. Among authors: frachet v. J Eur Acad Dermatol Venereol. 2024 Dec 7. doi: 10.1111/jdv.20483. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39644127 No abstract available.
[How can nature help us fight bacterial infections?].
Deschamps-Biboulet M, Fayolle T, Ziegelmeyer T, Frachet V. Deschamps-Biboulet M, et al. Among authors: frachet v. Med Sci (Paris). 2024 Mar;40(3):298-300. doi: 10.1051/medsci/2024018. Epub 2024 Mar 22. Med Sci (Paris). 2024. PMID: 38520109 French. No abstract available.
Symmetric CEST-active lanthanide complexes for redox monitoring.
Mouchel Dit Leguerrier D, Barré R, Ruet Q, Frachet V, Imbert D, Thomas F, Molloy JK. Mouchel Dit Leguerrier D, et al. Among authors: frachet v. Dalton Trans. 2022 Dec 13;51(48):18400-18408. doi: 10.1039/d2dt02776c. Dalton Trans. 2022. PMID: 36415954
[Separase, a key-player of mitosis: A new target for cancer therapy?].
Aouadi E, Fornier M, Gosseye A, Castillo-Ferrer C, Frachet V. Aouadi E, et al. Among authors: frachet v. Med Sci (Paris). 2021 Jun-Jul;37(6-7):684-686. doi: 10.1051/medsci/2021086. Epub 2021 Jun 28. Med Sci (Paris). 2021. PMID: 34180834 Free article. French. No abstract available.
Identification of pyrrolopyrimidine derivative PP-13 as a novel microtubule-destabilizing agent with promising anticancer properties.
Gilson P, Josa-Prado F, Beauvineau C, Naud-Martin D, Vanwonterghem L, Mahuteau-Betzer F, Moreno A, Falson P, Lafanechère L, Frachet V, Coll JL, Fernando Díaz J, Hurbin A, Busser B. Gilson P, et al. Among authors: frachet v. Sci Rep. 2017 Aug 31;7(1):10209. doi: 10.1038/s41598-017-09491-9. Sci Rep. 2017. PMID: 28860487 Free PMC article.
Investigation of chalcones as selective inhibitors of the breast cancer resistance protein: critical role of methoxylation in both inhibition potency and cytotoxicity.
Valdameri G, Gauthier C, Terreux R, Kachadourian R, Day BJ, Winnischofer SM, Rocha ME, Frachet V, Ronot X, Di Pietro A, Boumendjel A. Valdameri G, et al. Among authors: frachet v. J Med Chem. 2012 Apr 12;55(7):3193-200. doi: 10.1021/jm2016528. Epub 2012 Apr 2. J Med Chem. 2012. PMID: 22449016 Free PMC article.